Schizophrenia-like endurable behavioral and neuroadaptive changes induced by ketamine administration involve Angiotensin II AT1 receptor

被引:6
|
作者
Belen Occhieppo, Victoria [1 ]
Martin Basmadjian, Osvaldo [1 ]
Andrea Marchese, Natalia [2 ,3 ]
Jaime, Andrea [1 ]
Fernanda Perez, Mariela [1 ]
Baiardi, Gustavo [4 ]
Bregonzio, Claudia [1 ]
机构
[1] Univ Nacl Cordoba, Fac Ciencias Quim, Inst Farmacol Expt Cordoba IFEC CONICET, Dept Farmacol, Haya de la Torre S-N, Cordoba, Argentina
[2] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC, CONICET, Cordoba, Argentina
[3] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina
[4] Univ Nacl Cordoba, Univ Catolica Cordoba, Fac Ciencias Quim, Lab Neurofarmacol,IIBYT CONICET, Cordoba, Argentina
关键词
GABA; Parvalbumin; Positive signs; Negative signs; Cognitive deficit; ANTERIOR CINGULATE CORTEX; POSSIBLE ANIMAL-MODEL; COGNITIVE IMPAIRMENT; ANTAGONIST PREVENTS; NEGATIVE SYMPTOMS; INSULAR CORTEX; RAT BEHAVIOR; NEURONS; BRAIN; HYPOFUNCTION;
D O I
10.1016/j.bbr.2022.113809
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Schizophrenia is a chronic disease affecting 1% worldwide population, of which 30% are refractory to the available treatments: thus, searching for new pharmacological targets is imperative. The acute and repeated ketamine administration are validated preclinical models that recreate the behavioral and neurochemical features of this pathology, including the parvalbumin-expressing interneurons dysfunction. Angiotensin II, through AT(1) receptors (AT(1)-R), modulates the dopaminergic and GABAergic neurotransmission. We evaluated the AT(1)-R role in the long-term neuronal activation and behavioral alterations induced by repeated ketamine administration. Adult male Wistar rats received AT(1)-R antagonist candesartan/vehicle (days 1-10) and ketamine/saline (days 6-10). After 14 days of drug-free, neuronal activation and behavioral analysis were performed. Locomotor activity, social interaction and novel object recognition tests were assessed at basal conditions or after ketamine challenge. Immunostaining for c-Fos, GAD67 and parvalbumin were assessed after ketamine challenge in cingulate, insular, piriform, perirhinal, and entorhinal cortices, striatum, and hippocampus. Additionally, to evaluate the AT(1)-R involvement in acute ketamine psychotomimetic effects, the same behavioral tests were performed after 6 days of daily-candesartan and a single-ketamine administration. We found that ketamine-induced long-lasting schizophrenia-like behavioral alterations, and regional-dependent neuronal activation changes, involving the GABAergic neurotransmission system and the parvalbumin-expressing interneurons, were AT(1)-R-dependent. The AT(1)-R were not involved in the acute ketamine psychotomimetic effects. These results add new evidence to the wide spectrum of action of ketamine and strengthen the AT(1)-R involvement in endurable alterations induced by psychostimulants administration, previously proposed by our group, as well as their preponderant role in the development of psychiatric pathologies.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Carvedilol-induced antagonism of angiotensin II:: focus on AT1 receptor-alpha1 adrenoceptor crosstalk
    Batenburg, WW
    van Esch, JH
    Garrelds, IM
    Jorde, U
    van Kats, JP
    Saxena, PR
    Danser, AH
    [J]. HYPERTENSION, 2004, 44 (04) : 498 - 498
  • [42] Angiotensin II-induced association of phospholipase Cγ1 with the G-protein-coupled AT1 receptor
    Venema, RC
    Ju, H
    Venema, VJ
    Schieffer, B
    Harp, JB
    Ling, BN
    Eaton, DC
    Marrero, MB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (13) : 7703 - 7708
  • [43] TIMING OF PRENATAL DEVELOPMENTAL PERTURBATIONS INDUCED BY MUTANT DISC1 RESULTING IN SCHIZOPHRENIA-LIKE BEHAVIORAL AND PATHOLOGICAL ALTERATIONS
    Ayhan, Yavuz
    Vogel, M. W.
    Ross, C. A.
    Pletnikov, M. V.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 96 - 96
  • [44] AT1 receptor antagonism enhances angiotensin-II-facilitated carrageenan-induced paw edema
    Raghavendra, V
    Kulkarni, SK
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2000, 22 (08): : 633 - 636
  • [45] Regulation of angiotensin II AT1 and AT2 receptor expression by mechanical stretch induced myocyte hypertrophy
    Kijima, K
    Matsubara, H
    Murasawa, S
    Maruyama, K
    Mori, Y
    Komuro, I
    Yazaki, Y
    Inada, M
    [J]. HYPERTENSION, 1996, 28 (03) : P106 - P106
  • [46] Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland
    Sanchez-Lemus, Enrique
    Murakami, Yuki
    Larrayoz-Roldan, Ignacio M.
    Moughamian, Armen J.
    Pavel, Jaroslav
    Nishioku, Tsuyoshi
    Saavedra, Juan M.
    [J]. ENDOCRINOLOGY, 2008, 149 (10) : 5177 - 5188
  • [47] Endogenous angiotensin II suppresses stretch-induced ANP secretion via AT1 receptor pathway
    Oh, Young-Bin
    Gao, Shan
    Shah, Amin
    Kim, Jong Hun
    Park, Woo Hyun
    Kim, Suhn Hee
    [J]. PEPTIDES, 2011, 32 (02) : 374 - 381
  • [48] Involvement of the AT1 receptor in the venoconstriction induced by angiotensin II in both the inferior vena cava and femoral vein
    da Silva, Osmar Gomes
    Rossignoli, Patricia de Souza
    Carrillo-Sepulveda, Maria Alicia
    Morais Barreto-Chaves, Maria Luiza
    Chies, Agnaldo Bruno
    [J]. PEPTIDES, 2011, 32 (01) : 112 - 117
  • [49] C-tail of the AT1 receptor is required for angiotensin II-induced Src and ERK activation
    Sadoshima, J
    Modrall, G
    Nanamori, M
    Neubig, RR
    [J]. CIRCULATION, 1998, 98 (17) : 741 - 741
  • [50] The α2C-adrenoceptor antagonist JP-1302 controls behavioral parameters, tyrosine hydroxylase activity and receptor expression in a rat model of ketamine-induced schizophrenia-like deficits
    Tekin, Nurdan
    Karamahmutoglu, Tugba Eryigit
    Aykac, Asli
    Akakin, Dilek
    Gören, Mehmet Zafer
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2022, 221